ArticleGynecology and pelvic medicine2026
Comparison of outcomes between fertility-sparing and radical surgery in patients with pathological stage I epithelial ovarian cancer: a single-center retrospective cohort study.
Article in Gynecology and pelvic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fertility-sparing surgery (FSS) is increasingly considered for young patients with early-stage epithelial ovarian cancer, but evidence regarding its oncologic safety remains limited. We compared oncologic outcomes between FSS and radical surgery (RS) in patients with pathological International Federation of Gynecology and Obstetrics (FIGO) stage I epithelial ovarian cancer and described reproductive outcomes after FSS. Methods: We retrospectively reviewed patients with FIGO stage I epithelial ovarian cancer who underwent FSS or RS at West China Second University Hospital from 2013 to 2021. Clinicopathological, treatment, follow-up, oncologic, and reproductive data were extracted from medical records and follow-up data. Potential confounding was addressed using multivariable Cox regression and propensity score matching. Results: Among 472 patients, 425 underwent RS and 47 underwent FSS. Before matching, patients in the FSS group were younger and had more favorable tumor features; after matching, baseline characteristics were generally balanced. In the matched cohort, FSS and RS showed no significant differences in 5-year disease-free survival (DFS; 97.1% Conclusions: In this single-center retrospective cohort, FSS was not associated with significantly worse oncologic outcomes than RS in selected patients with pathological FIGO stage I epithelial ovarian cancer and was associated with favorable reproductive outcomes. Larger prospective studies with longer follow-up are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.